Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EU Clinical Trials Register information now available through WHO's International Clinical Trials Registry Platform 26 Marec 2012News European Medicines Agency Management Board strengthens conflicts of interest policies and transparency 26 Marec 2012Press releaseCorporate European Medicines Agency holds workshop on vaccines development against Schmallenberg virus 22 Marec 2012NewsMedicines Astellas Pharma Europe B.V. withdraws its application for an extension of the indication for Qutenza (capsaicin) 20 Marec 2012Press releaseHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 March 2012 16 Marec 2012NewsHuman European Medicines Agency issues recommendations for 2012/2013 seasonal flu vaccine composition 16 Marec 2012NewsHumanMedicines European Medicines Agency recommends transfer of manufacturing sites for Caelyx and Ceplene 16 Marec 2012Press releaseHumanMedicines European Medicines Agency confirms positive benefit-risk balance of Protelos / Osseor, but recommends new contraindications and revised warnings 16 Marec 2012Press releaseHumanMedicines Novartis Europharm Ltd withdraws its applications for an extension of the indication for Exelon and Prometax (rivastigmine) 15 Marec 2012Press releaseCorporate European Medicines Agency issues guidance on prevention of HIV transmission for public consultation 15 Marec 2012NewsHumanMedicines 1 … 256 257 258 259 260 Page 260 of 384 261 262 263 264 … 384
EU Clinical Trials Register information now available through WHO's International Clinical Trials Registry Platform 26 Marec 2012News
European Medicines Agency Management Board strengthens conflicts of interest policies and transparency 26 Marec 2012Press releaseCorporate
European Medicines Agency holds workshop on vaccines development against Schmallenberg virus 22 Marec 2012NewsMedicines
Astellas Pharma Europe B.V. withdraws its application for an extension of the indication for Qutenza (capsaicin) 20 Marec 2012Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 March 2012 16 Marec 2012NewsHuman
European Medicines Agency issues recommendations for 2012/2013 seasonal flu vaccine composition 16 Marec 2012NewsHumanMedicines
European Medicines Agency recommends transfer of manufacturing sites for Caelyx and Ceplene 16 Marec 2012Press releaseHumanMedicines
European Medicines Agency confirms positive benefit-risk balance of Protelos / Osseor, but recommends new contraindications and revised warnings 16 Marec 2012Press releaseHumanMedicines
Novartis Europharm Ltd withdraws its applications for an extension of the indication for Exelon and Prometax (rivastigmine) 15 Marec 2012Press releaseCorporate
European Medicines Agency issues guidance on prevention of HIV transmission for public consultation 15 Marec 2012NewsHumanMedicines